广东造血干细胞捐献突破900例 其中捐献境外21例

2020-07-07 王诗尧 中国新闻网

广东省红十字会副会长吴伟达6日介绍,截至目前,广东省累计报名造血干细胞捐献入库志愿捐献者数据达11万人份,累计捐献总数902例,其中为美国、法国、韩国等地境外患者捐献21例,捐献总数及库容使用率均居中

广东省红十字会副会长吴伟达6日介绍,截至目前,广东省累计报名造血干细胞捐献入库志愿捐献者数据达11万人份,累计捐献总数902例,其中为美国、法国、韩国等地境外患者捐献21例,捐献总数及库容使用率均居中国内地第一。

当天,3名志愿者分别在广州和深圳医院捐献造血干细胞,救助3名血液病患儿。广东非血缘关系造血干细胞捐献总数在内地率先突破900例。

白血病是造血系统恶性疾病,俗称“血癌”,内地白血病的发病率是十万分之五,每年新增病例4万多人,其中一半以上是青少年和儿童。造血干细胞移植是目前临床上治疗白血病、重症地中海贫血等疾病的有效治疗手段。

在今年上半年新冠肺炎疫情期间,广东省造血干细胞捐献量逆势增长,今年以来已有84位志愿者实现捐献,与去年同期相比增加17例,增长26%。

吴伟达介绍,广东是重症地中海贫血的高发区,白血病的发病率也很高,临床造血干细胞移植需求量大。目前中华骨髓库广东分库已拥有11万余人份的志愿捐献者资料,但还满足不了临床患者的移植需求。为了使更多的患者得到及时救助,还必须继续扩大资料库容量和提高库容使用率。广东省红十字会希望更多的健康适龄公民加入到志愿捐献者队伍中。

此外,为加强对爱心捐献人士、困难家庭的关爱,2020年广东省红十字会联合广东省陈绍常慈善基金会设立造血干细胞捐献人道关怀项目资金,用于广东省内造血干细胞捐献者的关怀慰问、困难救助以及科普宣传等,让更多罹患白血病、重症地贫等急需造血干细胞移植的患者得到救治。(完)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1758700, encodeId=714d1e5870050, content=<a href='/topic/show?id=0fc55652546' target=_blank style='color:#2F92EE;'>#捐献#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56525, encryptionId=0fc55652546, topicName=捐献)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2a37353309, createdName=新生儿张玉军, createdTime=Mon Feb 22 12:29:53 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025476, encodeId=c2d410254e67a, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Fri Jul 10 22:29:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271521, encodeId=e8b012e152186, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494739, encodeId=76441494e3983, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1758700, encodeId=714d1e5870050, content=<a href='/topic/show?id=0fc55652546' target=_blank style='color:#2F92EE;'>#捐献#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56525, encryptionId=0fc55652546, topicName=捐献)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2a37353309, createdName=新生儿张玉军, createdTime=Mon Feb 22 12:29:53 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025476, encodeId=c2d410254e67a, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Fri Jul 10 22:29:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271521, encodeId=e8b012e152186, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494739, encodeId=76441494e3983, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
    2020-07-10 独孤立克

    干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1758700, encodeId=714d1e5870050, content=<a href='/topic/show?id=0fc55652546' target=_blank style='color:#2F92EE;'>#捐献#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56525, encryptionId=0fc55652546, topicName=捐献)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2a37353309, createdName=新生儿张玉军, createdTime=Mon Feb 22 12:29:53 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025476, encodeId=c2d410254e67a, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Fri Jul 10 22:29:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271521, encodeId=e8b012e152186, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494739, encodeId=76441494e3983, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1758700, encodeId=714d1e5870050, content=<a href='/topic/show?id=0fc55652546' target=_blank style='color:#2F92EE;'>#捐献#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56525, encryptionId=0fc55652546, topicName=捐献)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2a37353309, createdName=新生儿张玉军, createdTime=Mon Feb 22 12:29:53 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025476, encodeId=c2d410254e67a, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Fri Jul 10 22:29:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271521, encodeId=e8b012e152186, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494739, encodeId=76441494e3983, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Thu Jul 09 13:29:53 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
    2020-07-09 俅侠

相关资讯

Blood:BET抑制剂CPI203可促进脐血HSC和巨噬细胞扩增

CPI203-处理的脐带血细胞保持骨髓再生能力;CPI203能促进人巨核细胞的体外发育。

Blood:Yap1-Scribble极化决定了造血干细胞的命运

造血干细胞对应激的适应反应取决于Yap1/Taz;在HSC命运决定中,Scribble连接Cdc42和Hippo信号级联的胞质功能。

Blood:EGFR依赖性的DNA修复促进造血再生

EGF通过激活DNA-PKcs和NHEJ促进HSC DNA修复和造血再生。 EGF在化疗后驱动造血细胞再生,并在放疗后促进人HSC恢复,同时增加HSC基因间突变

Blood:RET激活可改善造血干细胞的存活和扩增

通过GDNF/GFRa1激活GFL受体RET可改善LT-HSC体外培养时的存活和扩增和体内移植后的存活情况。

Blood:衰老诱导的IL27Ra信号可损伤造血干细胞

造血干细胞(HSC)衰老与骨髓增生相关疾病及免疫衰老的风险增加息息相关。

Blood:赖氨酸乙酰转移酶5(Tip60)参与造血干细胞稳态维持

条件性敲除小鼠造血系统中赖氨酸乙酰转移酶5(Tip60)可导致胎鼠和成年鼠的HSC缺失; Tip60通过H2A.Z的乙酰化调节参与维持HSC的关键生物学过程的基因。